knowledge -WSS

knowledge

author：leisure time 2025-10-01 23:38:43 - browse：316

UnitedHealthcare (UHC) health insurance company signage is displayed on an office building in Phoenix, Arizona — PATRICK T. FALLON/AFP via Getty Images

UnitedHealth Group has made it clear that more people, especially older adults, are seeing their doctors and getting more medical care this year. But that is certainly not dragging down the company’s profits.

In the third quarter of this year, UnitedHealth’s net profit increased by more than 11%, to more than $5.8 billion, the company reported Friday.

UnitedHealthcare, the health insurance division of the conglomerate, registered a medical loss ratio of 82.3% in the quarter. That means for every $100 in premiums the company collected, it paid out $82.30 to hospitals, doctors, and other providers — and kept the rest as profit and to cover its own expenses. That ratio was lower than the 82.8% that Wall Street had predicted for the quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Americans' trust in science, scientist continues decline: Report

focus

WSS

Scientists boost immune system in aging mice by making it youthful

Steward Health Care has deal to sell doctor network to UnitedHealth

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Pregnancy discrimination could be enabled by AI

Scientists boost immune system in aging mice by making it youthful

Food as medicine: Medically tailored meals may get standardized

leisure time

knowledge

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Spinal cord stimulation reduces pain in amputees, study finds

23andMe had bad news about my health. I wish a person had delivered it

Spinal cord stimulation reduces pain in amputees, study finds

Hepatitis C has a cure — but many Americans still lack access to it

States should stop sabotaging methadone treatment reform

Anesthesiologist group: stop taking Ozempic before surgery

Chemotherapy shortages won’t get better under Biden’s latest plan

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

There's no autism epidemic. It's an autism diagnosis epidemic

hotspot

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Patient advocates debate FDA's accelerated approval process

Leukemia patients are helped by Syndax's new type of therapy

Patients' immediate access to test results puts radiologists in a bind

Abortion pill case raises question: who can sue the FDA?

SCOTUS to consider access to abortion pill mifepristone

leisure time

entertainment

focus

focus